Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 121
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 2
You can read part 1 of our Looking Ahead series here. David Goubert, President & CEO, AYR Wellness MSOs will be focusing on the financial health of their companies, prioritizing cash flow generation and fostering leaner, more efficient operations.
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 1
2023 has been a significant year for cannabis across North America.
- Medical
Ukraine Makes ‘Historic Decision’ to Legalise Medical Cannabis
Ukraine has officially voted to legalise medical cannabis in what its Health Minister described as a ‘great victory for humanity and the beginning of a long journey’.
- Markets & Stocks
European Cannabis Stocks in 2023, MGC’s ArtemiC Approved in Saudi Arabia, & Panaxia Stock Skyrockets
European cannabis stocks in 2023 2023 has been perhaps the hardest financial year to date for the emerging European cannabis sector.
- Uncategorized
SOMAÍ Pharmaceuticals und Canify geben ihre Partnerschaft zur Einführung einer auf Cannabinoiden basierenden Produktlinie in Deutschland bekannt
SOMAÍ Pharmaceuticals und Canify AG geben ihre strategische Partnerschaft zur Einführung einer differenzierten Produktlinie auf Cannabinoidbasis in Deutschland bekannt SOMAÍ Pharmaceuticals Unipessoal LDA (SOMAÍ”), ein europäisches Pharma- und Biotechnologieunternehmen mit EU-GMP-Standard, das cannabinoidhaltige Arzneimittel weltweit vertreibt, gibt eine bahnbrechende dreijährige Marketing- und Vertriebsvereinbarung mit der Canify AG (Canify”) bekannt, einem lizenzierten pharmazeutischen Unternehmen, das sich…
- Press releases
SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
SOMAÍ Pharmaceuticals and Canify AG announce their strategic partnership to introduce a differentiated cannabinoid-based product line in Germany SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”), an EU-GMP European pharmaceutical and biotech company distributing cannabinoid-containing pharmaceuticals globally, announces a landmark three-year marketing & distribution agreement with Canify AG (“Canify”), a licensed pharmaceutical company focussing on medical cannabis.
- Uncategorized
Florida Files Bill to Remove 280E Tax Burdens as DeSantis’ Ties to Medical Cannabis Industry Brought Into Question
A Florida State Senator has filed a proposal which would relieve the 280E tax burden on medical cannabis businesses.
- Adult-Use
Alberta to Allow Cannabis Retails to Sell Products at Trade Shows and Festivals
The Canadian province of Alberta has announced plans to implement a swathe of changes to its retail cannabis regulations, including giving permission to cannabis retailers to operate temporary sales locations at trade-shows and festivals.
- Adult-Use
2023 Spotlight: Switzerland Establishes Europe’s Most Advanced Legal Adult-Use Cannabis Trial
Switzerland’s pioneering cannabis pilot project has developed into Europe’s most advanced and accessible adult-use framework throughout 2023.
- Uncategorized
Landmark Bill Allowing Medical Cannabis to Be Sold in Pharmacies Quashed by DEA in Georgia
Georgia’s ambitious plans to become the first US state to allow general pharmacies to dispense medical cannabis have been quashed by the Drug Enforcement Agency (DEA).
- Medical
2023 Spotlight: France’s Battle for Medical Cannabis
2023 has been a milestone year for European cannabis. Europe’s first fully legal adult-use cannabis stores have opened in Switzerland.
- Uncategorized
Six Synthetic Cannabinoids Placed in Schedule 1 in Effort to ‘Avoid Imminent Hazard to Public Safety’
The US Drug Enforcement Agency (DEA) has placed six ‘synthetic cannabinoids’ into a temporary Schedule 1 in an effort to ‘avoid imminent hazard to public safety’.
